Drugmakers tell court to keep hospitals out of their 340B rebate suits
Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed 340B drug rebate models. 340B Health and two of its ...
